Invention Grant
- Patent Title: Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
-
Application No.: US15097378Application Date: 2016-04-13
-
Publication No.: US09433618B2Publication Date: 2016-09-06
- Inventor: Xicheng Sun , Jian Qiu , Adam Stout
- Applicant: Nivalis Therapeutics, Inc.
- Applicant Address: US CO Boulder
- Assignee: Nivalis Therapeutics, Inc.
- Current Assignee: Nivalis Therapeutics, Inc.
- Current Assignee Address: US CO Boulder
- Agency: Swanson & Bratschun, L.L.C.
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61K31/4709 ; A61K31/4706
Abstract:
The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Public/Granted literature
- US20160220556A1 Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors Public/Granted day:2016-08-04
Information query
